#USA #Cambridge #NeuroSense #Aaron Lazar #ALS Podcast

Join Award-Winning Star Aaron Lazar in a Live Podcast on ALS Science

In a groundbreaking event set for August 4, 2025, actor and ALS advocate Aaron Lazar will host a live podcast featuring Alon Ben-Noon, the CEO of NeuroSense Therapeutics. This session is expected to shine a light on ALS science, the company's innovative treatment strategies, and their ongoing commitment to the ALS community.

A Confrontation of ALS

Lazar, an award-winning Broadway and film star, was diagnosed with amyotrophic lateral sclerosis (ALS) in January 2022. Since then, he has turned his personal battle into a mission to raise awareness and advocate for advancements in treatment. His spirited engagement in this podcast aims to confront the harsh realities of ALS while offering hope through scientific innovation.

Working alongside Ben-Noon, Lazar will delve into the specifics of PrimeC, NeuroSense's flagship investigational therapy designed to combat ALS effectively. Lazar's direct experience with the disease, in conjunction with Ben-Noon's insights, promises to provide the audience with a well-rounded perspective on the challenges and triumphs in the fight against this debilitating condition.

What to Expect from the Podcast

During the podcast, listeners can anticipate discussions focused on:

• - PrimeC's Development: Lazar will urge Ben-Noon to detail the scientific foundation and potential benefits of PrimeC, which combines two FDA-approved drugs targeted at critical mechanisms of ALS.
• - Regulatory Progress: Insights into NeuroSense's regulatory efforts in Canada will be shared, as the company seeks to gain rapid access to patients in dire need of effective therapies.
• - Community Engagement: The importance of community involvement in clinical trials and beyond will also be a focus, emphasizing how collective efforts are vital to advancing ALS research.
• - Live Q&A Session: Participants will have the unique opportunity to ask questions during the webcast, fostering a more interactive experience for attendees.

Register for the Event

The live podcast will be broadcast via Zoom on August 4 at 2:00 PM EST. Interested parties are encouraged to register through the provided link to take part in this essential discussion connecting healthcare professionals, ALS patients, and advocates in the field.

Register Here

About Aaron Lazar

Aaron Lazar is no stranger to the stage; celebrated for his work in productions such as The Phantom of the Opera and Les Miserables, he has won accolades for his performances. Recently, he has become a powerful voice in raising awareness about ALS. Lazar is not just advocating for treatment options but also inspiring many through his platform, The Impossible Dream, emphasizing the need for resilience and hope in the face of adversity.

About NeuroSense Therapeutics

NeuroSense is at the forefront of developing therapies for neurodegenerative diseases, with a keen focus on ALS. The company's vision is to address one of the vital unmet needs in modern medicine by creating effective treatments through innovative research. PrimeC, their leading clinical candidate, aims to catalyze significant change for ALS patients by potentially altering disease progression.

With a growing number of diagnoses each year, the work done by NeuroSense, in partnership with advocates like Lazar, exemplifies the intersection of science and community effort to cure ALS.

This live podcast will not only enrich the understanding of ALS pathology but also serve as a beacon of hope for patients and families affected by this serious disease. Don’t miss this opportunity to engage in a conversation that could inspire change in the ALS landscape.

Conclusion

As we await further details and the outcome of this event, it is clear that the fight against ALS is gaining momentum. With figures like Aaron Lazar stepping forward, paired with the scientific advancements at NeuroSense, there is substantial hope that effective treatments for ALS are on the horizon. Join the movement and witness the power of collaboration in action during this critical webcast.